31 related articles for article (PubMed ID: 27784426)
1. [Reversal Effect of Arctigenin on the Drug Resistance in Leukemia K562/A02 Cells and Its Mechanism].
Zou L; Fang Y; He W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):409-415. PubMed ID: 38660844
[TBL] [Abstract][Full Text] [Related]
2. NOD2 silencing promotes cell apoptosis and inhibits drug resistance in chronic lymphocytic leukemia by inhibiting the NF-κB signaling pathway.
Zheng C; Zhu Z; Weng S; Zhang Q; Fu Y; Cai X; Liu Z; Shi Y
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23510. PubMed ID: 37700718
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway.
Gao M; Liu L; Zhang X; Li Z; Zhang M
Environ Toxicol Pharmacol; 2021 Jul; 85():103639. PubMed ID: 33771682
[TBL] [Abstract][Full Text] [Related]
4. MHY1485 promotes adriamycin sensitivity in HepG2 cells by inhibiting autophagy.
Guo J; Lei Y; Liu L; Wen Z; Zhang B; Fang J; Liang G; Guo Q; Peng J
Funct Integr Genomics; 2024 Feb; 24(1):22. PubMed ID: 38306005
[TBL] [Abstract][Full Text] [Related]
5. Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3.
Li X; Yuan M; Song L; Wang Y
BMC Med Genet; 2020 Mar; 21(1):48. PubMed ID: 32138690
[TBL] [Abstract][Full Text] [Related]
6. [Effect and Mechanism of Atorvastatin on Reversing Drug Resistance in Leukemia by Regulating Glycolysis through PTEN/mTOR Pathway].
Liu M; Zhou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):38-44. PubMed ID: 36765474
[TBL] [Abstract][Full Text] [Related]
7. Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Matsuda T; Kishimoto K; Tanaka R; Tsurushima K; Ishizaka T; Nishida S
Clin Exp Med; 2023 Sep; 23(5):1597-1607. PubMed ID: 36451049
[TBL] [Abstract][Full Text] [Related]
8. Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway.
Yang C; Hou A; Yu C; Dai L; Wang W; Zhang K; Shao H; Ma J; Xu W
Onco Targets Ther; 2018; 11():983-996. PubMed ID: 29520149
[TBL] [Abstract][Full Text] [Related]
9. Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity.
Wu B; Li P; Qiu E; Chen J
BMC Pharmacol Toxicol; 2023 Oct; 24(1):50. PubMed ID: 37828612
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of Ferulic Acid on U937 Cell Growth and Its Related Mechanism].
Zheng J; Wu CC; Liu W; Jiang XX; Luo L; Deng YY; Li G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1278-1283. PubMed ID: 37846672
[TBL] [Abstract][Full Text] [Related]
11. [Effect of DR5-mediated docetaxel-loaded lipid microbubble combined with ultrasoundtargeted microbubble destruction on HepG2 cell proliferation and apoptosis].
Yang J; Zeng Y; Wu X; Wang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1220-1225. PubMed ID: 34549714
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-κB and p38 MAPK signaling pathways.
Zhang R; Lu M; Zhang Z; Tian X; Wang S; Lv D
Oncol Lett; 2016 Nov; 12(5):4147-4154. PubMed ID: 27895784
[TBL] [Abstract][Full Text] [Related]
13. [Role of inhibition of nuclear factor-kappa B gene transcription by specific miRNA in reversing multi-drug resistance of liver cancer].
Wang L; Cai Y; Shi Y; Yao M; Pan LH; Gu JJ; Yang XL; Wu W; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):493-499. PubMed ID: 27784426
[No Abstract] [Full Text] [Related]
14. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF
World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505
[TBL] [Abstract][Full Text] [Related]
15. [Abnormal expression of circulating nuclear factor-κB in hepatocellular carcinoma and reversal of multidrug resistance through intervening its gene transcription].
Yao M; Gu X; Wang L; Cai Y; Wu W; Shi Y; Dong Z; Yao D
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(10):761-6. PubMed ID: 27055634
[TBL] [Abstract][Full Text] [Related]
16. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
17. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer.
Wu J; Ding J; Yang J; Guo X; Zheng Y
Front Immunol; 2018; 9():546. PubMed ID: 29616037
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
